Sunday, June 21, 2020

Glenmark Pharmaceuticals Ltd – Drug for mild Covid patients hits market

Glenmark Pharmaceuticals Ltd  closes   at  409.10 with  a Gain    of   +0.90    on    19-June- 2020   with formation of  a  Green   Candle    on Daily  Price Chart.
About the Company : Glenmark Pharmaceuticals is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).
The Company  is  expected to Post Sales of 10579.90Cr & Net Profit of 728.70 Cr in FY2020 and Sales of 11532.10 Cr & Net Profit of 833.80 Cr in FY2021 and Sales of 12540.90 Cr & Net Profit of 963.20  Cr in FY2022.
Valuations  : The Company is now Trading at X 0.9  of its Value. We have valued the company with its  expected Financial Year 2020 earnings  , which is now almost ~10 %  Discount   to its value & X 0.81  of its FY20201 earning with a Discount  of ~ 19%   and X 0.72  of its FY20202  earning with a Discount  of ~ 28%.
Book Value will  increase  to  ₹ 230 Per Share ( ₹ 212 in FY2019 ). It will be ₹259 in FY2021 and ₹292 in FY2022.
Why Bullish : Glenmark has introduces drug for mild Covid patients , priced at Rs 103 a pill. ( Source : Media Report )
Margin of Safety (1Yr Bond Yield: Value>1 ) is now 1.7  ,which is  attractive.  its Future Price with its FY2022 earnings is 583.
Disclaimer : We are / may going to take exposure shortly.
Join Us at   Telegram #
Data Source | NSE Website | Screener.In  | Capital Line | Money Control |
The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

No comments:

Post a Comment

Thanks for Your Valuable comments. It will make Us to Serve You in Better Way. For Any STOCKS Query ,Please Call NiftyNext +91 880 2230 836.


The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.

Blog Archive